Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas


Creative Commons License

Samia P., Oyieke K., Tunje D., Udwadia-Hegde A., Feemster K., Anlar B., ...Daha Fazla

CURRENT TREATMENT OPTIONS IN NEUROLOGY, cilt.24, sa.3, ss.99-110, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 24 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s11940-022-00710-x
  • Dergi Adı: CURRENT TREATMENT OPTIONS IN NEUROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Sayfa Sayıları: ss.99-110
  • Anahtar Kelimeler: Treatment, Antiviral agent, Subacute sclerosing panencephalitis, Measles complication, SSPE, MEASLES-VIRUS, INTRAVENTRICULAR INTERFERON, SSPE, EPIDEMIOLOGY, IMMUNIZATION, VACCINATION, INOSIPLEX, DISEASE, PATIENT, ALPHA
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Purpose of the review Subacute sclerosing panencephalitis (SSPE) is a rare, slowly progressive, and frequently fatal neurodegenerative disorder caused by measles virus. The risk of SSPE remains significant globally, with fluctuating incidence noted in in tandem with measles vaccine uptake. This review aims to explore the current global status of SSPE, its treatment, and preventive measures.